Cabot (NYSE:CBT – Get Free Report) issued its earnings results on Monday. The specialty chemicals company reported $1.80 earnings per share for the quarter, missing the consensus estimate of $1.81 by ($0.01), Briefing.com reports. The business had revenue of $1 billion for the quarter, compared to analyst estimates of $1.01 billion. Cabot had a net margin of 12.05% and a return on equity of 26.99%. Cabot’s revenue was up 3.7% on a year-over-year basis. During the same quarter last year, the firm posted $1.65 earnings per share. Cabot updated its FY 2025 guidance to 7.400-7.800 EPS and its FY25 guidance to $7.40-7.80 EPS.
Cabot Price Performance
NYSE CBT traded down $1.93 during trading hours on Tuesday, reaching $108.16. 365,728 shares of the company’s stock were exchanged, compared to its average volume of 336,202. The firm has a fifty day moving average of $108.30 and a 200-day moving average of $101.01. The company has a current ratio of 2.22, a quick ratio of 1.45 and a debt-to-equity ratio of 0.72. Cabot has a one year low of $66.02 and a one year high of $117.14. The stock has a market cap of $5.93 billion, a PE ratio of 12.87, a price-to-earnings-growth ratio of 0.91 and a beta of 1.20.
Analysts Set New Price Targets
Several equities research analysts have recently weighed in on the company. Mizuho upped their price objective on Cabot from $103.00 to $122.00 and gave the company an “outperform” rating in a research note on Tuesday. JPMorgan Chase & Co. upped their price target on Cabot from $95.00 to $105.00 and gave the company a “neutral” rating in a research report on Wednesday, August 7th. Finally, UBS Group cut their price objective on Cabot from $103.00 to $98.00 and set a “neutral” rating for the company in a report on Tuesday, August 6th. Three research analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $105.00.
Insiders Place Their Bets
In other news, EVP Hobart Kalkstein sold 5,457 shares of the firm’s stock in a transaction on Tuesday, August 20th. The stock was sold at an average price of $100.58, for a total value of $548,865.06. Following the completion of the sale, the executive vice president now directly owns 61,688 shares in the company, valued at approximately $6,204,579.04. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. In related news, EVP Hobart Kalkstein sold 5,457 shares of the firm’s stock in a transaction that occurred on Tuesday, August 20th. The shares were sold at an average price of $100.58, for a total value of $548,865.06. Following the completion of the sale, the executive vice president now owns 61,688 shares of the company’s stock, valued at $6,204,579.04. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, EVP Jeff Ji Zhu sold 1,201 shares of the company’s stock in a transaction on Monday, August 26th. The stock was sold at an average price of $106.19, for a total value of $127,534.19. Following the transaction, the executive vice president now directly owns 96,000 shares in the company, valued at approximately $10,194,240. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 71,939 shares of company stock valued at $7,308,812. 3.07% of the stock is currently owned by corporate insiders.
Cabot Company Profile
Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.
Read More
- Five stocks we like better than Cabot
- What is MarketRank™? How to Use it
- Palantir Cracks $50, Is There Still Time to Get on Board?
- Stock Average Calculator
- Insider Buying Signals Upside for These 3 Stocks
- Low PE Growth Stocks: Unlocking Investment Opportunities
- These 2 Big Players Are Set to Compete With Elon Musk’s Starlink
Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.